The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued ...

Until now, the drugs have only been available from specialist NHS clinics or private pharmacies, costing around £150 to £200 for one month's supply.